Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2025-12-24 @ 7:41 PM
NCT ID:
NCT05924503
Eligibility Criteria:
Inclusion Criteria:
* \>18 years old on the day of enrollment
* Mechanical circulatory support
a. Left Ventricular Assist Device \[HeartMate-III\] in antegrade flow i. Critically ill ii. With and without pulsatility b. Impella antegrade flow c. VA-ECMO (VA-ECMO) is a temporary mechanical circulatory support system that enables complete and immediate cardiopulmonary support in the setting of cardiogenic shock and cardiac arrest) retrograde flow usual with femoral cannulation or antegrade flow if centrally cannulated
* Patient must be in the intensive care unit or in patient for the intervention to be performed
Exclusion Criteria:
* Known cerebrovascular disease or know angiographic abnormalities based on preexisting computed tomography angiography, digital subtraction angiography or transcranial Doppler prior to this hospitalization that will significantly affect Transcranial Doppler (TCD) parameters. Patients with abnormalities not likely to affect TCD parameters or known normal TCDs despite abnormal cerebral hemodynamic studies will still be included
* Pre-Existing neurological deficits impairing quality of life
* Absence of temporal windows
* Presence of skull defects that may affect the feasibility of TCD windows
* Co-existing dialysis or other forms of renal replacement therapy
* Pregnant patients
* Patients on palliative care pathway awaiting de-escalation
* Patient on comfort care
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05924503
Study Brief:
Protocol Section:
NCT05924503